Google’s Gemma AI model helps discover new potential cancer therapy pathway

How a Gemma model helped discover a new potential cancer therapy pathway

Oct 15, 2025, 4 min read

We’re launching a new 27 billion parameter foundation model for single-cell analysis built on the Gemma family of open models.

By Shekoofeh Azizi, Staff Research Scientist, Research Lead, Google DeepMind

and By Bryan Perozzi, Senior Staff Research Scientist, Graph Mining, Google Research

Share

Continue/Read Original Article Here: Google’s Gemma AI model helps discover new potential cancer therapy pathway

#2025 #AI #America #Cancer #CancerResearch #CancerTherapy #Education #Google #Health #Libraries #Library #Models #PotentialPathways #Research #Science #Technology #UnitedStates

Rakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.
#YonhapInfomax
#RakutenMedical #Alluminox #CancerTherapy #LotteBiologics #Photoimmunotherapy
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84992
Rakuten Medical CEO – 'Maintaining Quality of Life for Cancer Patients with Light-Based Therapy… Eyes on Korean Market'

Rakuten Medical is advancing its light-based Alluminox cancer therapy, aiming to minimize side effects and improve patient quality of life, with plans for global expansion and entry into the South Korean market through partnerships with Lotte Biologics and local ventures.

Yonhap Infomax

🧪Four years of #funding for personalized #cancertherapy!

The goal of the new LOEWE research cluster coordinated by Professor Torsten Frosch at TU Darmstadt is to measure drug levels directly at the bedside for immediate personalized adjustments.

GSI/FAIR Materials Research, led by Professor Toimil-Molares, is contributing with the development of special polymer membranes and sensors.

More 👉 https://www.gsi.de/en/start/news/details/2025/09/29/multidrug-tdm

© S. Keuth
© Moondance, Pixabay
#Cancer

Scientists have developed a ground-breaking treatment that forces cancer cells to produce their own anti-cancer drugs, effectively making them self-destruct. Instead of relying on external chemotherapy or radiation, this revolutionary approach reprograms tumour cells to turn against themselves and stop their own growth.

Researchers achieved this by delivering special genetic instructions into cancer cells, causing them to create targeted molecules that kill the tumour from within. This not only eliminates cancer cells but also spares healthy cells, greatly reducing the harsh side effects seen with traditional treatments.

Early trials are showing promising results, with tumours shrinking significantly and patients experiencing better recovery rates. Experts say this innovation could be a game-changer, offering a more precise and less toxic way to fight cancer while lowering the risk of recurrence.
This breakthrough is being hailed as one of the most exciting developments in oncology, potentially transforming cancer from a deadly disease into one that can be controlled, or even cured, from the inside out.

Cancer & Oncology
#Cancer #CancerResearch #Oncology #CancerTreatment #CancerBreakthrough #CancerCure #CancerInnovation #CancerTherapy #BeatCancer #CancerHope #CancerNews

Gene & Cell Therapy
#GeneTherapy #CellTherapy #GeneticEngineering #GeneEditing #SyntheticBiology #MolecularMedicine #PrecisionMedicine #RegenerativeMedicine

Biotech & Research
#Biotech #Biotechnology #MedicalResearch #LifeSciences #HealthTech #BioInnovation #ResearchMatters #MedicalBreakthrough #ScienceInnovation

Cutting-Edge Science
#ScienceNews #ScientificBreakthrough #FutureOfMedicine #NextGenMedicine #LabLife #ResearchCommunity #ScienceMatters #MedicalDiscovery

Hope & Awareness
#HopeInScience #HealingThroughScience #CureCancer #EndCancer #CancerAwareness #BetterTreatments #LessToxicTherapy

PhD candidate in photoactivated chemotherapy

Photoactivated chemotherapy (PACT) is a new form of phototherapy against cancer. In the frame of an Institute-funded programme dedicated to developing new photocages for cancer treatment, the group of Prof. Sylvestre Bonnet is looking for a chemist with proven experience in synthetic bioinorganic chemistry,…

Universiteit Leiden

I saw a scientifically and potentially clinically rather interesting presentation from Sniper therapeutics, this morning. But do we really need to militarize our technique and therapy names?

What was wrong with the original name Super Engagers?
Additionally, the mechanism of action here seems to be more 'close combat' than 'sniper'.

#Tcells #CancerTherapy #CellTherapy

Scientists have created a tiny DNA-based robot that can kill cancer cells by targeting them with incredible precision—without affecting healthy cells. This DNA nanodevice stays inactive in normal body conditions but springs into action only in the acidic environment found inside tumors. When it reaches a tumor, it unfolds and displays a special pattern of peptides (tiny protein fragments) that trigger cancer cells to self-destruct.
#Madtadon_science #CancerTherapy

Your gut microbes might be flushing cancer drugs from your system—thanks to what you eat. New research exposes this hidden interaction. #CancerTherapy #Microbiome #DrugResistance

https://geekoo.news/when-your-gut-bugs-weaken-cancer-drugs/

When Your Gut Bugs Weaken Cancer Drugs | Geekoo

A new study reveals how gut bacteria convert dietary compounds into molecules that can weaken cancer drugs. Understanding this hidden interaction could transform cancer therapy.

Geekoo
Hanmi Pharmaceutical partners with MSD for clinical trials on combination cancer therapy, focusing on HM16390 and Keytruda to potentially improve outcomes for advanced solid tumor patients.
#YonhapInfomax #HanmiPharmaceutical #MSD #ClinicalTrial #CancerTherapy #Immunotherapy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63794
Hanmi Pharm Collaborates with US-based MSD for Clinical Research on Combination Cancer Therapy

Hanmi Pharmaceutical partners with MSD for clinical trials on combination cancer therapy, focusing on HM16390 and Keytruda to potentially improve outcomes for advanced solid tumor patients.

Yonhap Infomax
×

🧪Four years of #funding for personalized #cancertherapy!

The goal of the new LOEWE research cluster coordinated by Professor Torsten Frosch at TU Darmstadt is to measure drug levels directly at the bedside for immediate personalized adjustments.

GSI/FAIR Materials Research, led by Professor Toimil-Molares, is contributing with the development of special polymer membranes and sensors.

More 👉 https://www.gsi.de/en/start/news/details/2025/09/29/multidrug-tdm

© S. Keuth
© Moondance, Pixabay
#Cancer